Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Internal Medicine
•
Rheumatology
•
Hematology
•
Pediatric Hematology
•
Lupus nephritis
•
Antiphospholipid Syndrome
•
Nephrology
•
Glomerulonephritis
•
Anticoagulation
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
Related Questions
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
How would you approach pursuing a kidney biopsy in a patient with suspected lupus nephritis who is on warfarin for antiphospholipid antibody syndrome?
How do you manage arthritis resulting from deferiprone in transfusion dependent thalassemia?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
How do you approach the management of patients with suspected membranous lupus nephritis who are found to have positive PLA2R antibodies?
Would you treat a patient aggressively for lupus nephritis if they have persistent proteinuria over 1 gram but cannot get a timely kidney biopsy?
How would you manage a patient with SLE that has a remote history of positive anti-phospholipid antibodies with a current DVT and now completely negative APLs?
What drives you to choose voclospsorin over tacrolimus given the substantially higher cost?
How do you manage a pregnant patient with lupus who develops renal disease during pregnancy that is not due to pre-eclampsia?